1020 Kifer Road
Sunnyvale , CA 94086
Sunnyvale , CA 94086
News
-
Intuitive Surgical Inc. eased 0.8% to $474.70 after the medical devices company reported first-quarter 2025 results.
Revenue surged to $2.25 billion from $1.89 billion, net income jumped to $698.4 million from $544.9 million, and diluted earnings per share rose to $1.92 from $1.51 a year ago.
The company guided fiscal 2025 worldwide da Vinci procedure growth to be between 15% and 17%, compared to 17% in 2024, including an estimated impact of tariffs of 1.7% of revenue, plus or minus 30 basis points.
Apr 23, 2025 -
Intuitive Surgical rose 3.3% to $385.0 after the robotic surgical equipment maker reported better-than-expected quarterly results.
Revenue in the first quarter increased 11% to $1.89 billion from $1.70 billion, net income rose to $547.4 million from $360.8 million, and diluted earnings per share advanced to $1.51 from $1.01 a year ago.
The company placed 313 da Vinci surgical systems, compared with 312 in the first quarter of 2023, and increased its installed base by 14% to 8,887 systems from 7,779 at the end of the first quarter of 2023.
Apr 19, 2024
Executive/
Director
Links
Price
- Last Close
-
$ 535.15
$ +10.84 2.07 %
Jan 3, 2025
- 52-Week High/Low
- $492.86 - $258.49
- YTD
- 2.5%
- Trading Volume
- 41,118
- Market Cap Full
- $ 188.4B
- Shares Outstanding
-
352.1M
Oct 16, 2023
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | 10.1% | 20.9% | 13.1% | 19.1% | -5% | -9.7% | -16% | -3.7% | 18.3% | 2.5% |
| Q2 | 10% | 22% | 19.4% | -10.2% | 4% | 24.5% | -33.5% | 33.9% | 12.8% | - |
| Q3 | 9.6% | 11.8% | 17.6% | 1% | 8% | 8.1% | -6.6% | -14.5% | 10.3% | - |
| Q4 | -12.5% | 3.2% | -16.7% | 9.7% | 15.1% | -63.9% | 41.6% | 14.4% | -3.1% | - |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2.5% | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | 12.1% | 2% | 3.5% | -8.6% | 10.6% | 10.4% | -0.5% | 10.3% | - | - | - | - |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3% | 16% | 73% | 31% | 23% | 39% | -56% | -26% | 27% | 55% | 2% |
Earnings
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Q1 | 3.67 | 4.67 | 2.44 | 2.56 | 2.62 | 3.51 | 1 | 1.00 |
| Q2 | 4.86 | 5.05 | 2.15 | 2.67 | 0.57 | 4.25 | 0.85 | 1.18 |
| Q3 | 5.39 | 2.55 | 2.45 | 3.33 | 2.6 | 1.04 | 0.9 | 1.16 |
| Q4 | 5.30 | 2.07 | 2.45 | 2.98 | 3.03 | 1.03 | 0.90 | - |
| A | 19.2 | 14.3 | 9.5 | 3.9 | 2.9 | 4.7 | 3.7 | 3.34 |
Annual Returns
52 Week
High/Low
Annual
Earnings
Chart
Trading Volume
Outstanding Shares
(In Millions) +
Jan 16, 2024
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Mar | - | 114.5 | 116 | 117.7 | 357.7 | 350.4 |
| Jun | 113.3 | 115.4 | 116.6 | 118.4 | 359 | 350.4 |
| Sep | 113.7 | 115.3 | 117 | 118.7 | 357.1 | 351.4 |
| Dec | 114.2 | 115.6 | 117.6 | 357.2 | 353.4 | 352.1 |
SEC Filings
Financial Ratios
| 2022 | 2021 | 2020 | 2019 | 2018 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Management | ||||||||||||||||||
| Inventory / Stock Turnover | 2.3 | 3 | 2.5 | 2.3 | 2.7 | |||||||||||||
| Fixed Asset Turnover | 1.2 | 0.9 | 1.3 | 1.2 | 1.4 | |||||||||||||
| Total Asset Turnover | 0.5 | 0.4 | 0.4 | 0.5 | 0.5 | |||||||||||||
| Leverage | ||||||||||||||||||
| Interest Coverage | 6.2 | 15.7 | -95.5 | -343.8 | 16.9 | |||||||||||||
| Debt Ratio | - | - | - | - | - | |||||||||||||
| Debt – Equity Ratio | - | - | - | - | - | |||||||||||||
| Equity multiplier | 0.5 | 0.5 | 0.3 | 0.5 | 0.4 | |||||||||||||